Stocksigma LogoStocksigma Logo

Tatva Chintan Pharma Chem Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)

■ Revenue: 2,173 (+75.9% YoY | +30.1% QoQ) ■ EBITDA: 407 (+83.2% YoY | +26.0% QoQ) ■ EBITDA Margin (%): 18.7 (+74 bps YoY | -61 bps QoQ) ■ PAT: 215

Tatva Chintan Pharma Chem Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)

Tatva Chintan Pharma Chem Ltd · Outcome · 19 Oct 2026, 9:22 pm

Tatva Chintan Pharma Chem Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 2,173 (+75.9% YoY | +30.1% QoQ) ■ EBITDA: 407 (+83.2% YoY | +26.0% QoQ) ■ EBITDA Margin (%): 18.7 (+74 bps YoY | -61 bps QoQ) ■ PAT: 215 (+116.3% YoY | +34.2% QoQ) ■ EPS (INR): 9.17 (+116.3% YoY | +34.3% QoQ)

Original exchange filing (PDF)

More announcements from Tatva Chintan Pharma Chem Ltd

All Tatva Chintan Pharma Chem Ltd announcements